IDEAYA Biosciences
George Cole Jr. is an accomplished medical professional with extensive experience in clinical development and leadership roles within the biopharmaceutical industry. Currently serving as the Head of Late Development and Senior Medical Director at IDEAYA Biosciences, George has also contributed to Certare Ventures, LLP as a Scientific Advisory Board Member. Prior roles include Vice President of Clinical Development at both Nurix Therapeutics and Nuvation Bio, as well as serving as Executive Medical Director at Nektar Therapeutics. George Cole Jr. holds an MD in Medicine from the Yale School of Medicine and a BA in Economics from Yale University.
This person is not in any teams
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California